Proteintech acquires ChromoTek
October 20, 2020 -- Proteintech, a German-based producer of antibodies, proteins, and immunoassays, has acquired ChromoTek, a manufacturer of camelid single-domain antibodies (aka nanobodies).
HJF to develop herpes virus vaccines
October 20, 2020 -- The Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF) and Citranvi Biosciences have signed an exclusive licensing agreement to develop vaccine technologies to prevent cytomegalovirus and Epstein-Barr virus infections.
Reaction Biology, 4HF Biotec offer new cell-based services
October 19, 2020 -- Reaction Biology and 4HF Biotec announced that they are offering a new cell-based service that will give customers a comprehensive understanding of their candidates. The service will combine Reaction's ProLiFiler cell assay service with 4HF's Biomarker Analysis and Mode of Action (MoA) Finder tools
Precigen nabs FDA nod for manufacturing UltraCAR-T therapies
October 15, 2020 -- Precigen has been granted clearance by the U.S. Food and Drug Administration (FDA) for its UltraPorator system. The system also had a successful technology transfer to clinical sites and will be used as a manufacturing device for Precigen's investigational UltraCAR-T therapies.
Thermo Fisher launches closed cell processing system
October 15, 2020 -- Thermo Fisher Scientific has launched the Gibco CTS Rotea counterflow centrifugation system, a modular, closed cell therapy processing system for cell therapy development and manufacturing.
Cellaria introduces new models to study pancreatic cancer
October 15, 2020 -- Cellaria has launched three new cell lines for pancreatic cancer that it hopes will improve patient care by improving the value of in vitro methods of developing therapies.
FDA approves first Ebola virus treatment
October 15, 2020 -- The U.S. Food and Drug Administration (FDA) has approved Inmazeb as the first FDA-approved treatment for Zaire ebolavirus (Ebola virus) infection in adult and pediatric patients.
FDA grants expanded access for Direct Biologics' ExoFlo
October 14, 2020 -- The U.S. Food and Drug Administration (FDA) granted expanded access for Direct Biologics' ExoFlo, allowing it to be used to treat patients with COVID-19-associated acute respiratory distress syndrome.
Axol Biosciences offers new screening assay for hiPSC-derived cells
October 13, 2020 -- Axol Biosciences has added multielectrode array screening services for human-induced pluripotent stem cell (hiPSC)-derived cells to its service offering for preclinical drug discovery.
Abveris, Immunitas partner on mAbs discovery
October 8, 2020 -- Abveris and Immunitas Therapeutics are partnering on the discovery of monoclonal antibodies (mAbs) to expand Immunitas' therapeutic pipeline.
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter